Testing effectiveness (Phase 2)Ended earlyNCT03850509
What this trial is testing
Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
Who this might be right for
Crohn's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 3